Axsome Therapeutics (AXSM) Net Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -23.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.43% |
| Dec 31, 2025 | 80.49% |
| Sep 30, 2025 | 90.48% |
| Jun 30, 2025 | 113.34% |
| Mar 31, 2025 | 73.62% |
| Dec 31, 2024 | 60.53% |
| Sep 30, 2024 | 156.86% |
| Jun 30, 2024 | -108.28% |
| Mar 31, 2024 | -219.88% |
| Dec 31, 2023 | -13.84% |
| Sep 30, 2023 | -113.33% |
| Jun 30, 2023 | 1,784.62% |
| Mar 31, 2023 | 2,687.71% |
| Dec 31, 2022 | 5.23% |
| Sep 30, 2022 | 679.50% |
| Jun 30, 2022 | 51.73% |
| Mar 31, 2022 | 90.82% |
| Dec 31, 2021 | -52.30% |
| Sep 30, 2021 | -327.74% |
| Jun 30, 2021 | -253.49% |
| Mar 31, 2021 | 15.17% |
| Dec 31, 2020 | -110.48% |
| Sep 30, 2020 | 215.50% |
| Jun 30, 2020 | -159.53% |
| Mar 31, 2020 | -179.05% |
| Dec 31, 2019 | 14,183.16% |
| Sep 30, 2019 | -97.07% |
| Jun 30, 2019 | 277.35% |
| Mar 31, 2019 | 487.85% |
| Dec 31, 2018 | -153.33% |
| Sep 30, 2018 | 18.83% |
| Jun 30, 2018 | 10.59% |
| Mar 31, 2018 | -187.95% |
| Dec 31, 2017 | -14.02% |
| Sep 30, 2017 | -29.57% |
| Jun 30, 2017 | -31.90% |
| Mar 31, 2017 | 312.24% |
| Dec 31, 2016 | -93.71% |
| Sep 30, 2016 | -172.03% |
| Jun 30, 2016 | -212.75% |
| Mar 31, 2016 | -326.82% |